Stockscreener 앱 받기
2.46
1.20%
-0.03
시장 영업 전:
2.39
-0.07
-2.85%
Equillium Inc 주식(EQ)의 최신 뉴스
EQ|Equillium Inc|Price:2.455|Chg%:-0.035 - TradingKey
Equillium Inc (EQ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Equillium Inc (EQ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Equillium Inc (EQ) Cash Flow - TradingKey
Equillium Inc (EQ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
EQ|Equillium Inc|Price:2.490|Chg%:-0.200 - TradingKey
EQ|Equillium Inc|Price:2.580|Chg%:+0.090 - TradingKey
Equillium Inc (EQ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Equillium Inc (EQ) Balance Sheet - TradingKey
Analysts Are Bullish on These Healthcare Stocks: Equillium (EQ), CSL (CMXHF) - The Globe and Mail
Equillium Inc (EQ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clear Street Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Equillium: The Market Seems To Have Already Priced In Phase 1 Success (NASDAQ:EQ) - Seeking Alpha
Clear Street Initiates Equillium(EQ.US) With Buy Rating, Announces Target Price $9 - Moomoo
Clear Street initiates Equillium stock with buy rating on IBD drug potential - Investing.com Nigeria
Piper Sandler Initiates Equillium(EQ.US) With Buy Rating, Announces Target Price $20 - Moomoo
Equillium Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains AbsentEarnings Revision Downgrade - dars.gov.et
EQUILLIUM INC : PIPER SANDLER INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $20 - webull.com
Piper Sandler Initiates Coverage on Equillium With Overweight Rating, $20 Price Target - marketscreener.com
EQ Initiated Coverage by Piper SandlerRating Set to Overweigh - GuruFocus
Piper Sandler initiates Equillium stock with overweight rating - Investing.com
ETFs Investing in Equillium, Inc. Stocks - TradingView
EQ Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Development CostsSaaS Earnings Trends - dars.gov.et
EQ Q1 2026 Earnings: EPS Misses Estimates as Company Continues Development-Stage OperationsEarnings Risk Report - dars.gov.et
Equillium(EQ) Stock Options Chain | Quotes & News - Moomoo
EQ News | EQUILLIUM INC (NASDAQ:EQ) - ChartMill
Equillium (EQ) Gets a Buy from Oppenheimer - The Globe and Mail
Equillium (EQ) Cantor Global Healthcare Conference 2025 Summary - Quartr
Roth MKM Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $12 - Moomoo
EQ Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Focuses on Pipeline ProgressPre-Earnings Setup - dars.gov.et
Equillium stock rating reaffirmed by Oppenheimer on rival drug data - Investing.com Canada
Equillium, Inc.(NasdaqCM: EQ) added to Russell 3000E Growth Benchmark - marketscreener.com
Equillium, Inc.(NasdaqCM: EQ) added to Russell Microcap Index - marketscreener.com
Equillium, Inc.(NasdaqCM: EQ) added to Russell 3000E Index - marketscreener.com
Equillium, Inc.(NasdaqCM: EQ) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Equillium Inc. (EQ) Q1 2026 Earnings: EPS Misses Estimates, Stock Gains 3.39% Amid Strategic Progress - dars.gov.et
Price to book forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Enterprise value to EBIT forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Price to sales forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Price to earnings forward of Equillium, Inc. – NASDAQ:EQ - TradingView
Equillium, Inc. Actuals & Estimates (NASDAQ:EQ) - TradingView
EQ Forecast — Price Target — Prediction for 2027 - TradingView
EQ Q1 2026 Earnings: EPS Miss Amid Pipeline Progress; Stock Rises 3%Special Dividend Alert - dars.gov.et
EQ Q1 2026 Earnings: EPS Miss Reflects Higher R&D Spend; Stock Gains SlightlyEarnings Revision Upgrade - dars.gov.et
EQUILLIUM INC (EQ) Stock Chart - ChartMill
23% Of This Equillium Insider's Holdings Were Sold - simplywall.st
Equillium Inc (EQ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Equillium Inc (EQ) Institutional Confidence - TradingKey
Equillium Inc (EQ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Equillium Inc (EQ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Equillium Inc. (EQ) Jumps 8.7%: Volume Surge and Key Resistance AheadCall Resistance - dars.gov.et
Equillium Inc. (EQ) Holds Steady at $2.81 – Key Support and Resistance Levels in FocusSystematic Flow - newsline.com
Equillium’s Lead Asset EQ504 Sees Growing Analyst Confidence Amid Pipeline ProgressDividend Cut Risk - newsline.com
Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504 - Insider Monkey
EQ Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesRevenue Miss Report - newsline.com
Equillium COO Christine Zedelmayer sells $42,736 in stock - Investing.com UK
1.97%
0.83%
자본화:
|
볼륨(24시간):